| Filed On | Filing |
|---|---|
| 23 Oct 2026 | 10-Q |
| 21 Oct 2026 |
8-K: Results of Operations and Financial Condition
PRINCETON, N.J., October 21, 2026 - Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today reported financial results for the third quarter ending September 30, 2026. |
| 19 Oct 2026 |
8-K: Entry into a Material Definitive Agreement; Termination of a Material Definitive Agreement +2 more
FARGO BANK, NATIONAL ASSOCIATION and MORGAN STANLEY BANK, N.A. |
| 13 Oct 2026 |
Form 3: Caruso Andrea B, CVP & CHRO
Holds 43,590 shares of Common Stock |
| 09 Oct 2026 |
8-K: Regulation FD Disclosure
PRINCETON, N.J., October 9, 2026 – Integra LifeSciences Holdings Corporation (NASDAQ:IART) (the “Company”) today announced the pricing of $450,000,000 aggregate principal amount of 9.500% senior secured notes due 2033 (the “Notes”). The ... |
| 02 Oct 2026 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
PRINCETON, N.J., October 2, 2026 – Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today provided certain unaudited preliminary third quarter results and an update to its full-year 2... |
| 28 Sep 2026 |
Form 3: Shinn Lesha R, CVP, Chief Legal Officer & Sec
Holds 26,838 shares of Common Stock |
| 08 Sep 2026 |
8-K: Regulation FD Disclosure
COLOR PALETTE Text 31 73 125 Title bar/Bullets 31 59 83 ACCENTS 1 31 59 83 140 179 212 2 30 105 142 143 202 231 3 47 177 52 165 231 167 4 54 132 156 166 210 224 5 140 181 202 209 225 234 6 191 191 191 229 229 229 Hyperlink 31 59 83 140 1... |
| 04 Sep 2026 |
Form 4: Veillon-Berteloot Chantal, EVP & CHRO
Gave up 1,455 shares to cover exercise price or tax ($24.2K) |
| 13 Aug 2026 | SCHEDULE 13G/A |
| 31 Jul 2026 | SCHEDULE 13G |
| 29 Jul 2026 | 10-Q |
| 29 Jul 2026 | 8-K: Results of Operations and Financial Condition |
| 06 Jul 2026 |
Form 4: Singh Harvinder, EVP & President, SS
Granted 5,590 Restricted Stock Units |
| 06 Jul 2026 |
Form 4: Mosebrook Jeffrey, SVP, Fin & Princ Acct Officer
Gave up 937 shares to cover exercise price or tax ($16.8K) |
| 06 Jul 2026 |
Form 4: Davis Robert T. Jr., EVP & President, TR&DT
Granted 11,180 Restricted Stock Units |
| 06 Jul 2026 |
Form 4: Knight Lea Daniels, EVP & Chief Financial Officer
Gave up 5,226 shares to cover exercise price or tax ($94.3K) |
| 03 Jun 2026 |
Form 4: McBreen Michael J., EVP & Chief Commercial Officer
Granted 60,372 Non-Qualified Stock Option (right to buy) · Granted 31,909 Restricted Stock Units |
| 03 Jun 2026 |
Form 4: Essig Stuart, Director
Granted 705,468 Non-Qualified Stock Option (right to buy) · Granted 365,297 Restricted Stock Units |
| 29 May 2026 | SD |
Loading...
